Sign In

Login

Password

Forgot Password ? Sign Up

Hodgkin-Lymphom (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Hodgkin-Lymphom" in German language version.

refsWebsite
Global rank German rank
37nih.gov
4th place
7th place
16doi.org
2nd place
3rd place
10zdb-katalog.de
123rd place
6th place
5wiley.com
222nd place
272nd place
3web.archive.org
1st place
1st place
3hematologylibrary.org
low place
low place
2ascopubs.org
low place
low place
1redirecter.toolforge.org
33rd place
2nd place
1lymphome.de
low place
low place
1leitlinienprogramm-onkologie.de
low place
9,990th place
1ghsg.org
low place
low place
1europa.eu
68th place
29th place

ascopubs.org

jco.ascopubs.org

doi.org

  • Henry H. Balfour Jr.: Progress, prospects, and problems in Epstein-Barr virus vaccine development. In: Current Opinion in Virology. Band 6, Juni 2014, ISSN 1879-6257, S. 1–5, doi:10.1016/j.coviro.2014.02.005.
  • Marius Goldkuhle, Maria Dimaki, Gerald Gartlehner, Ina Monsef, Philipp Dahm: Nivolumab for adults with Hodgkin’s lymphoma (a rapid review using the software RobotReviewer). In: Cochrane Database of Systematic Reviews. 12. Juli 2018, doi:10.1002/14651858.CD012556.pub2 (wiley.com [abgerufen am 9. Juli 2020]).
  • Sven Borchmann, Melita Cirillo u. a.: Pretreatment Vitamin D Deficiency Is Associated With Impaired Progression-Free and Overall Survival in Hodgkin Lymphoma. In: Journal of Clinical Oncology. 2019, doi:10.1200/JCO.19.00985.
  • Linus Knips, Nils Bergenthal, Fiona Streckmann, Ina Monsef, Thomas Elter: Aerobic physical exercise for adult patients with haematological malignancies. In: Cochrane Database of Systematic Reviews. 31. Januar 2019, doi:10.1002/14651858.CD009075.pub3 (wiley.com [abgerufen am 9. Juli 2020]).
  • Angela Aldin, Lisa Umlauff, Lise J. Estcourt, Gary Collins, Karel G. M. Moons: Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies. In: Cochrane Database of Systematic Reviews. 13. Januar 2020, doi:10.1002/14651858.CD012643.pub3 (wiley.com [abgerufen am 9. Juli 2020]).
  • Lise Estcourt, Simon Stanworth, Carolyn Doree, Sally Hopewell, Michael F. Murphy: Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation. In: Cochrane Database of Systematic Reviews. 16. Mai 2012, doi:10.1002/14651858.CD004269.pub3 (wiley.com [abgerufen am 9. Juli 2020]).
  • Lise J. Estcourt, Simon J. Stanworth, Carolyn Doree, Sally Hopewell, Marialena Trivella: Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. In: Cochrane Database of Systematic Reviews. 18. November 2015, doi:10.1002/14651858.CD010983.pub2 (wiley.com [abgerufen am 9. Juli 2020]).
  • Paul Lorigan, John Radford, Anthony Howell, Nick Thatcher: Lung cancer after treatment for Hodgkin’s lymphoma: a systematic review. In: The Lancet. Oncology. Band 6, Nr. 10, Oktober 2005, ISSN 1470-2045, S. 773–779, doi:10.1016/S1470-2045(05)70387-9, PMID 16198983.
  • Lindsay M. Morton, Graça M. Dores, Rochelle E. Curtis, Charles F. Lynch, Marilyn Stovall: Stomach cancer risk after treatment for hodgkin lymphoma. In: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. Band 31, Nr. 27, 20. September 2013, ISSN 1527-7755, S. 3369–3377, doi:10.1200/JCO.2013.50.6832, PMID 23980092, PMC 3770865 (freier Volltext).
  • Dennis A. Eichenauer, Indra Thielen, Heinz Haverkamp, Jeremy Franklin, Karolin Behringer: Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group. In: Blood. Band 123, Nr. 11, 13. März 2014, ISSN 1528-0020, S. 1658–1664, doi:10.1182/blood-2013-07-512657, PMID 24478403.
  • Dennis A. Eichenauer, Indra Thielen, Heinz Haverkamp, Jeremy Franklin, Karolin Behringer: Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group. In: Blood. Band 123, Nr. 11, 13. März 2014, ISSN 1528-0020, S. 1658–1664, doi:10.1182/blood-2013-07-512657, PMID 24478403.
  • Anthony J. Swerdlow, Craig D. Higgins, Paul Smith, David Cunningham, Barry W. Hancock: Second cancer risk after chemotherapy for Hodgkin’s lymphoma: a collaborative British cohort study. In: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. Band 29, Nr. 31, 1. November 2011, ISSN 1527-7755, S. 4096–4104, doi:10.1200/JCO.2011.34.8268, PMID 21969511.
  • Amit Sud, Hauke Thomsen, Kristina Sundquist, Richard S. Houlston, Kari Hemminki: Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History. In: Journal of Clinical Oncology. Band 35, Nr. 14, 10. Mai 2017, ISSN 0732-183X, S. 1584–1590, doi:10.1200/JCO.2016.70.9709, PMID 28384078, PMC 5455705 (freier Volltext).
  • Andrea K. Ng, M. V. Patricia Bernardo, Edie Weller, Kendall Backstrand, Barbara Silver: Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. In: Blood. Band 100, Nr. 6, 15. September 2002, ISSN 0006-4971, S. 1989–1996, doi:10.1182/blood-2002-02-0634, PMID 12200357.
  • Michael Schaapveld, Berthe M. P. Aleman, Anna M. van Eggermond, Cécile P. M. Janus, Augustinus D. G. Krol: Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma. In: New England Journal of Medicine. Band 373, Nr. 26, 24. Dezember 2015, ISSN 0028-4793, S. 2499–2511, doi:10.1056/NEJMoa1505949.
  • F. E. van Leeuwen, W. J. Klokman, A. Hagenbeek, R. Noyon, A. W. van den Belt-Dusebout: Second cancer risk following Hodgkin's disease: a 20-year follow-up study. In: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. Band 12, Nr. 2, Februar 1994, ISSN 0732-183X, S. 312–325, doi:10.1200/JCO.1994.12.2.312, PMID 8113838.

europa.eu

ema.europa.eu

ghsg.org

hematologylibrary.org

bloodjournal.hematologylibrary.org

leitlinienprogramm-onkologie.de

lymphome.de

nih.gov

ncbi.nlm.nih.gov

  • A. Zambelli u. a.: Hodgkin’s disease as unusual presentation of post-transplant lymphoproliferative disorder after autologous hematopoietic cell transplantation for malignant glioma. In: BMC Cancer. Band 5, 23. August 2005, S. 109, PMID 16117828
  • S. Caillard u. a.: Myeloma, Hodgkin disease, and lymphoid leukemia after renal transplantation: characteristics, risk factors and prognosis. In: Transplantation. Band 81, Nr. 6, 27. März 2006, S. 888–895. PMID 16570013
  • S. Mathas u. a.: Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma. In: Nature Immunology. Band 7, Nr. 2, 2006, S. 207–215, PMID 16369535
  • J. S. Knight u. a.: Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase. In: PNAS. Band 102, Nr. 51, 2005, S. 18562–18566, PMID 16352731, PMC 1317900 (freier Volltext)
  • J. Cossman u. a.: Reed-Sternberg cell genome expression supports a B-cell lineage. In: Blood. Band 94, Nr. 2, 1999, S. 411–416, PMID 10397707.
  • E. Rizos u. a.: Acquired icthyosis: a paraneoplastic skin manifestation of Hodgkin’s disease. In: The Lancet Oncology. Band 3, Nr. 12, 2002, S. 727, PMID 12473513
  • W. Tilakaratne und M. Dissanayake: Paraneoplastic pemphigus: a case report and review of literature. In: Oral Diseases. Band 11, Nr. 5, September 2005, S. 326–329. PMID 16120122
  • B. C. Oh u. a.: A case of Hodgkin’s lymphoma associated with sensory neuropathy. In: J Korean Med Sci. Band 19, Nr. 1, Februar 2004, S. 130–133, PMID 14966355
  • S. Kung u. a.: Delirium resulting from paraneoplastic limbic encephalitis caused by Hodgkin’s disease. In: Psychosomatics. Band 43, Nr. 6, November-Dezember 2002, S. 498–501, PMID 12444235.
  • T. Shinohara u. a.: Pathology of pure hippocampal sclerosis in a patient with dementia and Hodgkin’s disease: the Ophelia syndrome. In: Neuropathology. Band 25, Nr. 4, Dezember 2005, S. 353–360, PMID 16382785.
  • M. M. Thakker u. a.: Multifocal nodular episcleritis and scleritis with undiagnosed Hodgkin’s lymphoma. In: Ophthalmology. Band 110, Nr. 5, Mai 2003, S: 1057–1060, PMID 12750114.
  • G. Schellong: Cooperative therapy study HD 78 for Hodgkin’s disease in children and adolescents. In: Monatsschrift für Kinderheilkunde Band 127, Nr. 8, August 1979, S. 487–489, PMID 470955
  • YE Deutsch, T Tadmor, ER Podack, u. a. CD30: an important new target in hematologic malignancies. In: Leukemia & Lymphoma. Band 52, 2011, S. 1641–1654 PMID 21619423
  • N. M. Okeley, J. B. Miyamoto, Zhang X. u. a. Intracellular activation of SGN-35, a potent anti-CD30 anti-body-drug conjugate. In: Clinical Cancer Research. Band 16, 2010, S. 888–897, PMID 20086002
  • A. Rothe, S. Sasse, H. Goergen u. a.: Brentuximab vedotin for relapsed or refractory CD30+ hematologic malignancies: the German Hodgkin Study Group experience. In: Blood. Band 120, 2012, S. 1470–1472, PMID 22786877
  • A. Younes, A. K. Gopal, S. E. Smith u. a.: Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin’s Lymphoma. In: Journal of Clinical Oncology. Band 30, 2012, S. 2183–2189, PMID 22454421
  • B. Pro, R. Advani, P. Brice u. a.: Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study. In: Journal of Clinical Oncology. Band 30, 2012, S. 2190–2196, PMID 22614995
  • N. Schmitz, A. Sureda: The role of allogeneic stem-cell transplantation in Hodgkin’s disease. In: Eur J Haematol Suppl. Band 66, Juli 2005, S. 146–149, PMID 16007884
  • I. Alvarez u. a.: Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed hodgkin lymphoma: results of a spanish prospective cooperative protocol. In: Biology of Blood and Marrow Transplantation. Band 12, Nr. 2, Februar 2006, S. 172–183, PMID 16443515
  • A. Engert u. a.: Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin’s lymphoma: results of the HD8 trial of the German Hodgkin’s Lymphoma Study Group. In: Journal of Clinical Oncology. Band 21, Nr. 19, 2003, S. 3601–3608. PMID 12913100
  • V. Diehl u. a.: Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin’s disease. In: NEJM. Band 353, Nr. 7, 2005, S. 744, PMID 12802024.
  • R. Kuppers u. a.: Advances in biology, diagnostics, and treatment of Hodgkin’s disease. In: Biology of Blood and Marrow Transplantation. Band 12, Nr. 1, Supplement 1, Januar 2006, S. 66–76, PMID 16399588
  • A. Josting u. a.: A new prognostic score based on treatment outcome of patients with relapsed Hodgkin lymphoma registered in the database of the German Hodgkin Lymphoma Study Group (GHSG). In: Journal of Clinical Oncology. Band 20, 2002, S. 221–230, PMID 11773173
  • A. Josting u. a.: Prognostic factors and treatment outcome in primary progressive Hodgkin’s lymphoma – a report from the German Hodgkin’s Lymphoma Study Group (GHSG). In: Blood. Band 96, 2000, S. 1280–1286, PMID 10942369.
  • Paul Lorigan, John Radford, Anthony Howell, Nick Thatcher: Lung cancer after treatment for Hodgkin’s lymphoma: a systematic review. In: The Lancet. Oncology. Band 6, Nr. 10, Oktober 2005, ISSN 1470-2045, S. 773–779, doi:10.1016/S1470-2045(05)70387-9, PMID 16198983.
  • Lindsay M. Morton, Graça M. Dores, Rochelle E. Curtis, Charles F. Lynch, Marilyn Stovall: Stomach cancer risk after treatment for hodgkin lymphoma. In: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. Band 31, Nr. 27, 20. September 2013, ISSN 1527-7755, S. 3369–3377, doi:10.1200/JCO.2013.50.6832, PMID 23980092, PMC 3770865 (freier Volltext).
  • Dennis A. Eichenauer, Indra Thielen, Heinz Haverkamp, Jeremy Franklin, Karolin Behringer: Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group. In: Blood. Band 123, Nr. 11, 13. März 2014, ISSN 1528-0020, S. 1658–1664, doi:10.1182/blood-2013-07-512657, PMID 24478403.
  • Dennis A. Eichenauer, Indra Thielen, Heinz Haverkamp, Jeremy Franklin, Karolin Behringer: Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group. In: Blood. Band 123, Nr. 11, 13. März 2014, ISSN 1528-0020, S. 1658–1664, doi:10.1182/blood-2013-07-512657, PMID 24478403.
  • G. M. Dores u. a.: Second malignant neoplasms among long-term survivors of Hodgkin’s disease: a population-based evaluation over 25 years. In: Journal of Clinical Oncology. Band 20, Nr. 16, 2002, S. 3484–3494, PMID 12177110.
  • Anthony J. Swerdlow, Craig D. Higgins, Paul Smith, David Cunningham, Barry W. Hancock: Second cancer risk after chemotherapy for Hodgkin’s lymphoma: a collaborative British cohort study. In: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. Band 29, Nr. 31, 1. November 2011, ISSN 1527-7755, S. 4096–4104, doi:10.1200/JCO.2011.34.8268, PMID 21969511.
  • Amit Sud, Hauke Thomsen, Kristina Sundquist, Richard S. Houlston, Kari Hemminki: Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History. In: Journal of Clinical Oncology. Band 35, Nr. 14, 10. Mai 2017, ISSN 0732-183X, S. 1584–1590, doi:10.1200/JCO.2016.70.9709, PMID 28384078, PMC 5455705 (freier Volltext).
  • Andrea K. Ng, M. V. Patricia Bernardo, Edie Weller, Kendall Backstrand, Barbara Silver: Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. In: Blood. Band 100, Nr. 6, 15. September 2002, ISSN 0006-4971, S. 1989–1996, doi:10.1182/blood-2002-02-0634, PMID 12200357.
  • F. E. van Leeuwen, W. J. Klokman, A. Hagenbeek, R. Noyon, A. W. van den Belt-Dusebout: Second cancer risk following Hodgkin's disease: a 20-year follow-up study. In: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. Band 12, Nr. 2, Februar 1994, ISSN 0732-183X, S. 312–325, doi:10.1200/JCO.1994.12.2.312, PMID 8113838.
  • T. Hodgkin: On some morbid appearances of the absorbent glands and spleen. In: Medico-Chirurgical Transactions. (London) Band 17, 1832, S. 68–114, PMID 4630498.
  • L. S. Goodman u. a.: Use of methyl-bis(beta-chloroethyl)amine hydrochloride for Hodgkin’s disease, lymphosarcoma, leukemia. In: JAMA. Band 132, 1946, S. 126, PMID 6368885
  • V. T. DeVita Jr. u. a.: Combination chemotherapy in the treatment of advanced Hodgkin’s disease. In: Annals of Internal Medicine. Band 73, 1970, S. 881, PMID 5525541
  • M. Medetti: Nitrogen mustards in the treatment of children. In: Osp Maggiore. Band 40, Nr. 1, Januar 1952, S. 38–40, PMID 14941617.

redirecter.toolforge.org

web.archive.org

wiley.com

doi.wiley.com

  • Marius Goldkuhle, Maria Dimaki, Gerald Gartlehner, Ina Monsef, Philipp Dahm: Nivolumab for adults with Hodgkin’s lymphoma (a rapid review using the software RobotReviewer). In: Cochrane Database of Systematic Reviews. 12. Juli 2018, doi:10.1002/14651858.CD012556.pub2 (wiley.com [abgerufen am 9. Juli 2020]).
  • Linus Knips, Nils Bergenthal, Fiona Streckmann, Ina Monsef, Thomas Elter: Aerobic physical exercise for adult patients with haematological malignancies. In: Cochrane Database of Systematic Reviews. 31. Januar 2019, doi:10.1002/14651858.CD009075.pub3 (wiley.com [abgerufen am 9. Juli 2020]).
  • Angela Aldin, Lisa Umlauff, Lise J. Estcourt, Gary Collins, Karel G. M. Moons: Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies. In: Cochrane Database of Systematic Reviews. 13. Januar 2020, doi:10.1002/14651858.CD012643.pub3 (wiley.com [abgerufen am 9. Juli 2020]).
  • Lise Estcourt, Simon Stanworth, Carolyn Doree, Sally Hopewell, Michael F. Murphy: Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation. In: Cochrane Database of Systematic Reviews. 16. Mai 2012, doi:10.1002/14651858.CD004269.pub3 (wiley.com [abgerufen am 9. Juli 2020]).
  • Lise J. Estcourt, Simon J. Stanworth, Carolyn Doree, Sally Hopewell, Marialena Trivella: Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. In: Cochrane Database of Systematic Reviews. 18. November 2015, doi:10.1002/14651858.CD010983.pub2 (wiley.com [abgerufen am 9. Juli 2020]).

zdb-katalog.de

  • Henry H. Balfour Jr.: Progress, prospects, and problems in Epstein-Barr virus vaccine development. In: Current Opinion in Virology. Band 6, Juni 2014, ISSN 1879-6257, S. 1–5, doi:10.1016/j.coviro.2014.02.005.
  • Paul Lorigan, John Radford, Anthony Howell, Nick Thatcher: Lung cancer after treatment for Hodgkin’s lymphoma: a systematic review. In: The Lancet. Oncology. Band 6, Nr. 10, Oktober 2005, ISSN 1470-2045, S. 773–779, doi:10.1016/S1470-2045(05)70387-9, PMID 16198983.
  • Lindsay M. Morton, Graça M. Dores, Rochelle E. Curtis, Charles F. Lynch, Marilyn Stovall: Stomach cancer risk after treatment for hodgkin lymphoma. In: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. Band 31, Nr. 27, 20. September 2013, ISSN 1527-7755, S. 3369–3377, doi:10.1200/JCO.2013.50.6832, PMID 23980092, PMC 3770865 (freier Volltext).
  • Dennis A. Eichenauer, Indra Thielen, Heinz Haverkamp, Jeremy Franklin, Karolin Behringer: Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group. In: Blood. Band 123, Nr. 11, 13. März 2014, ISSN 1528-0020, S. 1658–1664, doi:10.1182/blood-2013-07-512657, PMID 24478403.
  • Dennis A. Eichenauer, Indra Thielen, Heinz Haverkamp, Jeremy Franklin, Karolin Behringer: Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group. In: Blood. Band 123, Nr. 11, 13. März 2014, ISSN 1528-0020, S. 1658–1664, doi:10.1182/blood-2013-07-512657, PMID 24478403.
  • Anthony J. Swerdlow, Craig D. Higgins, Paul Smith, David Cunningham, Barry W. Hancock: Second cancer risk after chemotherapy for Hodgkin’s lymphoma: a collaborative British cohort study. In: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. Band 29, Nr. 31, 1. November 2011, ISSN 1527-7755, S. 4096–4104, doi:10.1200/JCO.2011.34.8268, PMID 21969511.
  • Amit Sud, Hauke Thomsen, Kristina Sundquist, Richard S. Houlston, Kari Hemminki: Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History. In: Journal of Clinical Oncology. Band 35, Nr. 14, 10. Mai 2017, ISSN 0732-183X, S. 1584–1590, doi:10.1200/JCO.2016.70.9709, PMID 28384078, PMC 5455705 (freier Volltext).
  • Andrea K. Ng, M. V. Patricia Bernardo, Edie Weller, Kendall Backstrand, Barbara Silver: Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. In: Blood. Band 100, Nr. 6, 15. September 2002, ISSN 0006-4971, S. 1989–1996, doi:10.1182/blood-2002-02-0634, PMID 12200357.
  • Michael Schaapveld, Berthe M. P. Aleman, Anna M. van Eggermond, Cécile P. M. Janus, Augustinus D. G. Krol: Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma. In: New England Journal of Medicine. Band 373, Nr. 26, 24. Dezember 2015, ISSN 0028-4793, S. 2499–2511, doi:10.1056/NEJMoa1505949.
  • F. E. van Leeuwen, W. J. Klokman, A. Hagenbeek, R. Noyon, A. W. van den Belt-Dusebout: Second cancer risk following Hodgkin's disease: a 20-year follow-up study. In: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. Band 12, Nr. 2, Februar 1994, ISSN 0732-183X, S. 312–325, doi:10.1200/JCO.1994.12.2.312, PMID 8113838.